Oncolytics Biotech Inc. (TSX:ONC)
Canada
· Delayed Price · Currency is CAD 0.4850
-0.0100 (-2.02%)
May 30, 2025, 12:47 PM EDT
Oncolytics Biotech Employees
Oncolytics Biotech had 28 employees as of December 31, 2024. The number of employees decreased by 1 or -3.45% compared to the previous year.
Employees
28
Change
-1
Growth
-3.45%
Revenue / Employee
n/a
Profits / Employee
-1.13M CAD
Market Cap
43.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Trulieve Cannabis | 6,000 |
| dentalcorp Holdings | 10,200 |
| Green Thumb Industries | 4,800 |
| Sienna Senior Living | 12,263 |
| Extendicare | 23,000 |
| Cronos Group | 459 |
| WELL Health Technologies | 1,507 |
| Curaleaf Holdings | 5,519 |
Oncolytics Biotech News
- 7 days ago - Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities - PRNewsWire
- 15 days ago - Oncolytics Biotech Inc. (ONCY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum - PRNewsWire
- 16 days ago - Oncolytics Biotech Q1 2025 Earnings Preview - Seeking Alpha
- 16 days ago - A Look at Oncolytics Biotech's Upcoming Earnings Report - Benzinga
- 24 days ago - Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights - PRNewsWire
- 5 weeks ago - Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action - PRNewsWire
- 7 weeks ago - Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital - PRNewsWire